PCSA short interest
Processa Pharmaceuticals Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 4,140 |
|---|---|
| Change vs prior report | -10,855 (-72.4%) |
| Change over six months | -92.8% |
| Days to cover | 1.00 (sector: 3.78) |
| Average daily volume | 23,095 |
| Rank in Healthcare | not ranked (OTC, fund or thinly traded) |
PCSA short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 4,140 | -72.4% | 1.00 | 23,095 |
| 2026-09-15 | 14,995 | -58.3% | 1.00 | 29,028 |
| 2026-08-31 | 35,949 | -46.6% | 1.01 | 35,705 |
| 2026-08-14 | 67,319 | -68.8% | 1.00 | 78,571 |
| 2026-07-31 | 215,851 | +108.4% | 1.00 | 953,671 |
| 2026-07-15 | 103,554 | +20.3% | 1.40 | 74,139 |
| 2026-06-30 | 86,054 | -4.4% | 1.98 | 43,464 |
| 2026-06-15 | 89,983 | -1.2% | 1.14 | 78,796 |
| 2026-05-29 | 91,063 | -21.9% | 1.60 | 56,774 |
| 2026-05-15 | 116,594 | -13.9% | 1.92 | 60,842 |
| 2026-04-30 | 135,440 | +30.3% | 1.88 | 71,903 |
| 2026-04-15 | 103,916 | +80.6% | 1.34 | 77,459 |
| 2026-03-31 | 57,548 | +45.7% | 1.31 | 44,079 |
| 2026-03-13 | 39,505 | +278.1% | 1.05 | 37,680 |
| 2026-02-27 | 10,448 | +0.9% | 1.00 | 25,125 |
| 2026-02-13 | 10,356 | -65.5% | 1.00 | 66,959 |
| 2026-01-30 | 29,972 | -0.4% | 1.00 | 53,268 |
| 2026-01-15 | 30,093 | -69.3% | 1.00 | 114,015 |
| 2025-12-31 | 98,000 | -97.2% | 1.00 | 4,086,107 |
| 2025-12-15 | 3,454,719 | -36.4% | 1.73 | 1,992,460 |
| 2025-11-28 | 5,434,144 | +1.4% | 4.28 | 1,269,544 |
| 2025-11-14 | 5,357,542 | -40.8% | 2.14 | 2,499,949 |
| 2025-10-31 | 9,049,525 | -34.2% | 1.39 | 6,497,050 |
| 2025-10-15 | 13,756,678 | +416.7% | 1.00 | 41,055,609 |
| 2025-09-30 | 2,662,436 | +192.8% | 1.00 | 3,106,819 |
import finzdata as yf
yf.Ticker("PCSA").short_interest # every report since 2017
yf.Client().short_interest(["PCSA"], start="2018-01-01")Healthcare short interest · PCSA price history · Who owns PCSA · All short interest